Novel Tau Based Immunoassay Identifies Alzheimer's Pathology - Presented By Alzpath

Novel tau based immunoassay identifies Alzheimer's pathology - Presented by ALZpath

Samba Scientific

Tau Protein Pathology in Alzheimer's Disease

TauRxTherapeutics

Plasma p-tau181 to identify Alzheimer’s disease-related co-pathology in DLB

Revealing the Neuropathology of Alzheimer’s Disease Through Novel Fluid and Imaging Biomarkers

Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD

Alzheimer's disease subtypes identified based on blood proteomics

Investigating novel plasma-based P-tau biomarkers

Markers of of tau pathology in Alzheimer’s disease

Tau Spread As Alzheimer's Progresses - The Brain and Tau Pathology Mini Series

TauRxTherapeutics

Beyond Aβ and p-Tau: novel biomarkers under investigation for Alzheimer’s disease

Astrocyte biomarkers associated with amyloid-β and tau pathologies

The pathology of dementia, and the role of the tau and beta-amyloid protein in Alzheimer’s disease

Future of tau-targeting immunotherapies in Alzheimer’s disease

Comparing the performance of novel biomarkers across the spectrum of Alzheimer’s disease

Targeting Tau in Alzheimer's Disease

TauRxTherapeutics

APOE TREM and Microglia in the Pathogenesis of Tau-mediated Neurodegeneration with David Holtzman MD

University of California Television (UCTV)

Alzheimer's disease - plaques, tangles, causes, symptoms & pathology

Osmosis from Elsevier

New Blood Test for Alzheimer’s Disease

Investigate Explore Discover

Prions | Mechanisms and Theories of Alzheimers Disease (Amyloid & Tau)

Catalyst University

Biomarkers in dementia with Lewy bodies: αSyn RT-QuIC